These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1897639)

  • 1. Opiate system in self-injurious behavior.
    Chernaik SJ
    Am J Psychiatry; 1991 Oct; 148(10):1421-2. PubMed ID: 1897639
    [No Abstract]   [Full Text] [Related]  

  • 2. Deficiency in the opioid hypotheses of self-injurious behavior.
    King BH; McCracken JT; Poland RE
    Am J Ment Retard; 1991 May; 95(6):692-4; discussion 694-6. PubMed ID: 1647799
    [No Abstract]   [Full Text] [Related]  

  • 3. Role for opioid peptides in self-injurious behavior: dissociation from autonomic nervous system functioning.
    Herman BH; Hammock MK; Egan J; Arthur-Smith A; Chatoor I; Werner A
    Dev Pharmacol Ther; 1989; 12(2):81-9. PubMed ID: 2714161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can self-injury be viewed as an addictive behavior in adolescents? Aspects of the pathogenesis of self-injury behavior].
    Resch F; Karwautz A; Schuch B; Lang E
    Z Kinder Jugendpsychiatr; 1993 Dec; 21(4):253-9. PubMed ID: 8147128
    [No Abstract]   [Full Text] [Related]  

  • 5. Rationale for the administration of opiate antagonists in treating infantile autism.
    Deutsch SI
    Am J Ment Defic; 1986 May; 90(6):631-5. PubMed ID: 2872816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous opiates and self-mutilation.
    Richardson JS; Zaleski WA
    Am J Psychiatry; 1986 Jul; 143(7):938-9. PubMed ID: 3717448
    [No Abstract]   [Full Text] [Related]  

  • 7. Opioid neuronal denervation in Gilles de la Tourette syndrome.
    Sandyk R
    Int J Neurosci; 1987 Jul; 35(1-2):95-8. PubMed ID: 3040612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of endorphins in opiate addiction, opiate withdrawal, and recovery.
    Gold MS; Rea WS
    Psychiatr Clin North Am; 1983 Sep; 6(3):489-520. PubMed ID: 6359093
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of naloxone on self-injurious behavior: a case study.
    Davidson PW; Kleene BM; Carroll M; Rockowitz RJ
    Appl Res Ment Retard; 1983; 4(1):1-4. PubMed ID: 6307142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-injurious behavior: a review of the behavior and biology of self-mutilation.
    Winchel RM; Stanley M
    Am J Psychiatry; 1991 Mar; 148(3):306-17. PubMed ID: 1847025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone attenuates self-abusive behavior in developmentally disabled clients.
    Sandman CA; Datta PC; Barron J; Hoehler FK; Williams C; Swanson JM
    Appl Res Ment Retard; 1983; 4(1):5-11. PubMed ID: 6870234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical excitement to sedative-hypnotics in mentally retarded clients.
    Barron J; Sandman CA
    Am J Ment Defic; 1985 Sep; 90(2):124-9. PubMed ID: 2996351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An opioid deficit in borderline personality disorder: self-cutting, substance abuse, and social dysfunction.
    New AS; Stanley B
    Am J Psychiatry; 2010 Aug; 167(8):882-5. PubMed ID: 20693463
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacotherapy for self-injurious behavior: preliminary tests of the D1 hypothesis.
    Gualtieri CT; Schroeder SR
    Psychopharmacol Bull; 1989; 25(3):364-71. PubMed ID: 2626514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone decreases self-injurious behavior.
    Herman BH; Hammock MK; Arthur-Smith A; Egan J; Chatoor I; Werner A; Zelnik N
    Ann Neurol; 1987 Oct; 22(4):550-2. PubMed ID: 3481242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opiate receptors and their implications for drug addiction.
    Simon EJ
    NIDA Res Monogr; 1980 Mar; 30():303-8. PubMed ID: 6256635
    [No Abstract]   [Full Text] [Related]  

  • 17. Opiates, endorphins, and the developing organism: a comprehensive bibliography, 1982-1983.
    Zagon IS; McLaughlin PJ; Zagon E
    Neurosci Biobehav Rev; 1984; 8(3):387-403. PubMed ID: 6390269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for maintenance pharmacotherapy of opiate dependence.
    Kreek MJ
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral metabolism in opiate-dependent subjects: effects of methadone maintenance.
    Galynker II; Watras-Ganz S; Miner C; Rosenthal RN; Des Jarlais DC; Richman BL; London E
    Mt Sinai J Med; 2000; 67(5-6):381-7. PubMed ID: 11064488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous hydromorphone: effects in opiate-free and methadone maintenance subjects.
    McCaul ME; Stitzer ML; Bigelow GE; Liebson IA
    NIDA Res Monogr; 1983 Apr; 43():238-44. PubMed ID: 6192340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.